Current Findings and Potential Mechanisms of KarXT (Xanomeline–Trospium) in Schizophrenia Treatment
Ali Azargoonjahromi
Topics & Concepts
Schizophrenia (object-oriented programming)AntipsychoticMuscarinic acetylcholine receptorMedicineTolerabilityTardive dyskinesiaAgonistPositive and Negative Syndrome ScalePharmacologyAdverse effectAnticholinergicPsychologyPsychosisReceptorInternal medicinePsychiatryReceptor Mechanisms and SignalingSchizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior